.
Originally reported by Psychiatry Online. Read more
Source: https://www.psychiatryonline.org/doi/full/10.1176/appi.pn.2026.04.4.3
Archive summary Clinical & research
MedCheck: FDA Approves Novel Antipsychotic Milsaperidone; Designates Psilocybin Analogue as Breakthrough Therapy for Postpartum Depression, and More
Newsletter
The weekly digest
Weekly digest of US behavioral health policy and regulation, source-linked and practitioner-edited. Free; unsubscribe in one click.